Sponsor to Organization vs. Direct Investigator Agreements: Pros & Cons

Edye Edens from KLF highlights the key differences between sponsor-to-organization agreements and direct investigator agreements. Larger research organizations and academic medical centers often prefer sponsor-to-organization agreements because they provide structured negotiations around intellectual property (IP) rights, indirect costs, liability protections, and compliance oversight. These agreements also ensure that investigators have access to institutional resources and support.

On the other hand, direct investigator agreements may offer a faster turnaround, but they come with greater risks. Investigators negotiating independently might agree to terms that organizations would typically reject, potentially exposing themselves to legal and financial liabilities.

Understanding these distinctions is crucial for managing risk. While direct agreements may have their place, it’s essential to carefully evaluate the terms and ensure adequate protections. If you're unsure about the best approach for your situation, consult legal experts before signing. Need guidance? Get in touch with KLF.

Support the show